000 03540nam a22004335i 4500
999 _c6143
_d6143
001 6143
003 ES-MaUEC
005 20200618160038.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 191023s2020 gw | s |||| 0|eng d
020 _a9783030286460
024 7 _a10.1007/978-3-030-28646-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280
_b.B5 2020 EB
100 1 _aGoonewardene, Sanchia
_eautor
_4aut
_9673114
245 1 0 _aManagement of Non-Muscle Invasive Bladder Cancer
_cby Sanchia S. Goonewardene, Raj Persad, Hanif Motiwala, David Albala.
250 _a1st ed. 2020.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2020.
300 _a1 recurso en línea (XXIV, 402 páginas)
_b 20 ilustraciones, 19 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aBladder cancer survivorship -- Survivor burdens unmet needs -- CPEX testing in bladder cancer -- Management of low, intermediate and high risk bladder cancer -- Neoadjuvant chemotherapy in muscle invasive bladder cancer -- Multimodal therapy for muscle invasive bladder cancer -- None Muscle invasive bladder cancer- chemotherapy or resection -- Muscle invasive bladder cancer- open, laparoscopic or roboticG3 NMIBC- BCG versus cystectomy -- Role of immunotherapy in bladder cancer -- Robotic Surgery and bladder cancer -- Quality of life post Cystectomy -- The Neobladder and Quality of life -- Ileal conduit versus neobladder, which is better? -- Quality of life post NMIBC or BCG -- Rarc technical tips and tricks -- Robotic Surgery and resection -- Robotic radical cystectomy and PLND -- Robotic cystectomy and sentinal node mapping -- Robotic cystectomy and neobladder formation -- Robotic cystectomy and enhanced recovery -- Robotic radical cystectomy, pain and enhanced recovery -- Enhanced recovery and hypoalbumineamia -- The Robotic approach to redo surgery -- Robotic cystectomy and ureteric strictures -- BCG and cystectomy -- BCG and secondary malignancy. .
520 3 _aThis book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors. Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
650 7 _2embne
_9667082
_aVejiga
_xCáncer
700 1 _aPersad, Raj
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9674067
700 1 _aMotiwala, Hanif
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9674068
700 1 _aAlbala, David M.
_eautor
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_9674069
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9783030286453
776 0 8 _iPrinted edition:
_z9783030286477
776 0 8 _iPrinted edition:
_z9783030286484
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-28646-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
_n0
998 _db
_zSI